Comerica Bank’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-315
Closed -$628 3778
2025
Q1
$628 Sell
315
-758
-71% -$1.93K ﹤0.01% 3592
2024
Q4
$3.13K Buy
1,073
+758
+241% +$2.66K ﹤0.01% 3401
2024
Q3
$1.22K Sell
315
-181
-36% -$838 ﹤0.01% 3555
2024
Q2
$2.55K Sell
496
-155
-24% -$940 ﹤0.01% 3443
2024
Q1
$4.56K Sell
651
-663
-50% -$5.03K ﹤0.01% 3358
2023
Q4
$11.6K Buy
1,314
+535
+69% +$4.12K ﹤0.01% 3120
2023
Q3
$7.43K Buy
+779
New +$10.1K ﹤0.01% 3260

Other funds holding PRME

Comerica Bank's PRME Position: Q2 2025 in Review

Comerica Bank sold out of Prime Medicine (PRME) in Q2 2025, closing a stake of 315 shares — an estimated $628 sold.

Comerica Bank first reported a position in PRME in Q3 2023 and held it in 7 quarters. The position peaked at $11.6K in Q4 2023. 121 funds tracked by Wall St. Rank hold PRME as of Q2 2025.

  • Comerica Bank reported no remaining Prime Medicine position as of Q2 2025 after selling out during the quarter.
  • Comerica Bank sold 315 Prime Medicine shares in Q2 2025, an estimated $628.
  • Comerica Bank first reported a position in Prime Medicine in Q3 2023 and held it in 7 quarters.
  • Comerica Bank's Prime Medicine position peaked at $11.6K in Q4 2023.
  • 121 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2025.

Based on Comerica Bank's 13F filing for Q2 2025, filed 14 Aug 2025.